Track Align Technology's EBIT ($650M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
Align Technology (ALGN) currently reports a EBIT of $650M as of September 2026. That compares with $530M in the prior-year period — up 20.7% year over year. That is below the Healthcare sector average of $1.9T. Use the charts on this page to explore Align Technology's EBIT history and peer comparisons.
Align Technology's EBIT increased from $530M to $650M — a 20.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Align Technology's EBIT of $650M is lower than the Healthcare sector average of $1.9T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Align Technology reported $650M in EBIT as of September 2026. That compares with $530M in the prior-year period — up 20.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $650M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $1.9T. From there, open related valuation or income-statement pages for Align Technology, and consider following ALGN for alerts when major investors trade the stock.